New Zealand Government Neglects E-Liquid Regulation, Thousands of Retailers at Risk

Regulations by 2FIRSTS.ai
Apr.10.2024
New Zealand Government Neglects E-Liquid Regulation, Thousands of Retailers at Risk
Thousands of e-liquid retailers in New Zealand may escape legal consequences due to lack of government oversight.

According to the New Zealand media nzdoctor on April 10, if the New Zealand government continues to turn a blind eye and invest in the wrong areas, thousands of e-liquid retailers may potentially operate outside the law. Letitia Harding, CEO of the Asthma and Respiratory Foundation NZ, stated that the news of Health Ministry layoffs was regrettable but not surprising.

 

According to our understanding, they are not the ones enforcing the law on the thousands of e-liquid retailers. What we hope to see is the government shifting its focus towards investing in this area.

 

A survey conducted last year revealed that the Department of Health's e-liquid Regulatory Authority (VRA) has only one full-time employee, while the regulatory manager works only 10 hours per week, equivalent to a total of three-and-a-half full-time employees.

 

The foundation visited an e-liquid retailer last week and observed many non-compliant products. Hardin stated that the government has not committed to limiting the number of specialist e-liquid retailers (SVRs), of which there are currently 1530, so there is a need for continued investment in e-liquid compliance.

 

They need to invest in people who conduct door-to-door product inspections to ensure all products meet regulatory requirements. Perhaps this task should not fall on the Department of Health, but instead be handled by the Department of Legal Affairs, similar to how alcohol selling venues are regulated. Without this investment, our young people will continue to be addicted to e-cigarettes.

 

According to information provided to the foundation under the Official Information Act (OIA), the e-liquid regulatory authority has initiated an investigation into a company that operates two e-liquid websites for failing to comply with new e-liquid laws. This investigation comes after examining 29 websites to ensure compliance with safety requirements, including the company's failure to include removable batteries with products, not meeting nicotine strength labeling requirements, and not installing child safety mechanisms.

 

In order to protect the company's right to a fair trial, the Health Department has not disclosed the name and website domain of the company. The department has confirmed that no fines have been issued to date, but stated that "violations are not necessarily punishable offenses" in this case.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
BAT’s Vuse Ultra listed as GOOD DESIGN Awards winner; features app connectivity and adjustable intensity
British American Tobacco’s (BAT) Vuse Ultra vaping product has been listed among winners on the U.S. GOOD DESIGN Awards website, in the “Personal Experience” category, according to the project page. The page identifies the award year as 2025 and names BAT (London) as both the entrant and the manufacturer.
Jan.20 by 2FIRSTS.ai
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
Feb.11
South Korea online purchasing fuels spread among younger groups; online drug cases share climbs
South Korea online purchasing fuels spread among younger groups; online drug cases share climbs
Police said detections of new drugs disguised as e-cigarettes reached 1,206 cases through September last year, up from 941 in 2022, and the number of detected drug types increased from 26 to 33 over the same period.
Feb.11 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Nicaragua’s Health Ministry reaffirms Resolution No. 334-2021, maintaining a total ban on vaping and e-cigarette sales
Nicaragua’s Health Ministry reaffirms Resolution No. 334-2021, maintaining a total ban on vaping and e-cigarette sales
Nicaragua’s Ministry of Health (MINSA) issued an official statement on January 2, 2026 reaffirming the validity of Ministerial Resolution No. 334-2021, which absolutely bans the use and commercialization of electronic nicotine delivery systems known as “vapeadores” or e-cigarettes.
Jan.04 by 2FIRSTS.ai
Product | ELFBAR launches new “4-in-1” e-cigarette kit: 4× (1ml + 5ml) design, 4 flavors per set
Product | ELFBAR launches new “4-in-1” e-cigarette kit: 4× (1ml + 5ml) design, 4 flavors per set
ELFBAR has launched the “4 in 1 Ultra 50 VAPE KIT” through multiple online sales channels in the UK. The kit combines four 1ml prefilled pods with four 5ml refill containers. The company claims it can deliver up to around 50,000 puffs, with a retail price of approximately £13.99.
Dec.31 by 2FIRSTS.ai